From Lab Bench to Commercial Scale
Process scale-up is the bridge between a promising discovery and a commercially viable product. Yet, it remains one of the most challenging phases in biopharmaceutical development.
The Most Common Pitfalls
1. Underestimating Process Variability
What works consistently at the 10 L scale may behave very differently at 2,000 L. Parameters such as mixing dynamics, heat transfer, and dissolved oxygen profiles change non-linearly with scale.
Solution:
Establish a robust Design of Experiments (DoE) program early and model scale-dependent parameters before committing to a manufacturing scale.
2. Inadequate Technology Transfer Documentation
Poor documentation during technology transfer is a leading cause of failed batches and costly delays.
Solution:
Use structured technology transfer protocols with clear acceptance criteria, and leverage AI-enabled tools to ensure documentation completeness and consistency.
3. Overlooking Equipment Qualification
IQ/OQ/PQ activities are often treated as a formality rather than a genuine quality gate.
Solution:
Build qualification activities into the project timeline from day one — not as an afterthought.
How quai-litysystems Supports Scale-Up
Our consulting team brings hands-on experience across multiple scale-up programs. We help you:
- Define critical process parameters (CPPs) and critical quality attributes (CQAs)
- Develop robust process characterization studies
- Build manufacturing documentation that stands up to regulatory scrutiny
Scaling up doesn’t have to be a leap of faith — with the right support, it can be a well-engineered transition.